Centeon turnaround helping RPR profits
Executive Summary
Pharmaceutical sector operating profits increased 33.1% in the second quarter to $198 mil. "due to an improvement in product mix and the first positive effect from the recovery of Centeon," the firm's plasma products joint venture with Hoechst. Pharma sector sales were up 6.2% to $1.4 bil. during the quarter